3GJW
PARP complexed with A968427
Summary for 3GJW
Entry DOI | 10.2210/pdb3gjw/pdb |
Related | 2RCW 2RD6 3GJW |
Descriptor | Poly [ADP-ribose] polymerase 1, 7-(pyrrolidin-1-ylmethyl)pyrrolo[1,2-a]quinoxalin-4(5H)-one (3 entities in total) |
Functional Keywords | protein-inhibitor complex, acetylation, adp-ribosylation, dna damage, dna repair, dna-binding, glycosyltransferase, metal-binding, nad, nucleus, phosphoprotein, polymorphism, transferase, zinc, zinc-finger |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 39436.14 |
Authors | Park, C.H. (deposition date: 2009-03-09, release date: 2010-03-09, Last modification date: 2023-09-06) |
Primary citation | Miyashiro, J.,Woods, K.W.,Park, C.H.,Liu, X.,Shi, Y.,Johnson, E.F.,Bouska, J.J.,Olson, A.M.,Luo, Y.,Fry, E.H.,Giranda, V.L.,Penning, T.D. Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1) Bioorg.Med.Chem.Lett., 19:4050-4054, 2009 Cited by PubMed Abstract: Based on screening hit 1, a series of tricyclic quinoxalinones have been designed and evaluated for inhibition of PARP-1. Substitutions at the 7- and 8-positions of the quinoxalinone ring led to a number of compounds with good enzymatic and cellular potency. The tricyclic quinoxalinone class is sensitive to modifications of both the amine substituent and the tricyclic core. The synthesis and structure-activity relationship studies are presented. PubMed: 19553114DOI: 10.1016/j.bmcl.2009.06.016 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.3 Å) |
Structure validation
Download full validation report
